Adcock Ingram Holdings Limited's latest marketcap:
As of 07/28/2025, Adcock Ingram Holdings Limited's market capitalization has reached $566.97 M. According to our data, Adcock Ingram Holdings Limited is the 13450th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 566.97 M |
| Revenue (ttm) | 538.44 M |
| Net Income (ttm) | 42.53 M |
| Shares Out | 146.76 M |
| EPS (ttm) | 0.28 |
| Forward PE | 13.10 |
| Ex-Dividend Date | 03/12/2025 |
| Earnings Date | 08/22/2025 |
Adcock Ingram Holdings Limited's yearly market capitalization.
| Date | Market Cap(R) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/28/2025 | R10.13 B | $566.97 M | 2.99% | 13450 |
| 12/31/2024 | R9.83 B | $516.24 M | 7.1% | 12767 |
| 12/29/2023 | R9.18 B | $501.3 M | 12.42% | 12973 |
| 12/30/2022 | R8.17 B | $478.57 M | 0.07% | 12546 |
| 12/31/2021 | R8.16 B | $510.86 M | 5.94% | 13208 |
| 12/31/2020 | R7.7 B | $520.73 M | -16.45% | 11385 |
| 12/31/2019 | R9.22 B | $653.68 M | -13.82% | 8706 |
| 12/31/2018 | R10.7 B | $740.36 M | 6.94% | 7266 |
| 12/29/2017 | R10 B | $804.39 M | 20.93% | 8138 |
| 12/30/2016 | R8.27 B | $598.14 M | -1.99% | 8795 |
Company Profile
About Adcock Ingram Holdings Limited
Adcock Ingram Holdings Limited, along with its subsidiaries, is a leading manufacturer, marketer, and distributor of healthcare products across Southern Africa and India. The company serves both private and public sectors, delivering a diverse range of medical and wellness solutions.
Business Divisions
The company operates through four key divisions:
- Consumer: Sells healthcare, personal care, and homecare products via FMCG retailers and corporate pharmacies.
- Over the Counter (OTC): Distributes medicinal products through corporate and independent pharmacies.
- Prescription: Offers branded and generic prescription medications, as well as specialized instrumentation and surgical products.
- Hospital Products and Services: Provides critical care solutions, including intravenous fluids, blood collection products, and renal dialysis systems.
Product Portfolio
Adcock Ingram's extensive product range covers:
- Allergies, antiretrovirals, and baby care
- Cardiovascular, cannabidiol, and central nervous system treatments
- Colds, flu, cough, and respiratory solutions
- Dermatology, digestive well-being, and gastroenterology
- Energy boosters, feminine hygiene, and food/nutrition supplements
- Generics, ophthalmology, and pain management
- Personal care, vitamins, minerals, and women’s health products
Company Background
Founded in 1890, Adcock Ingram Holdings Limited is headquartered in Midrand, South Africa, with a long-standing reputation for quality healthcare solutions.
Frequently Asked Questions
-
What is Adcock Ingram Holdings Limited's (JSE-AIP) current market cap?As of 07/28/2025, Adcock Ingram Holdings Limited (including the parent company, if applicable) has an estimated market capitalization of $566.97 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Adcock Ingram Holdings Limited (JSE-AIP) rank globally by market cap?Adcock Ingram Holdings Limited global market capitalization ranking is approximately 13450 as of 07/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.